Avantax Planning Partners’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-46
Closed -$3K 637
2018
Q3
$3K Buy
+46
New +$2.42K ﹤0.01% 1251
2018
Q2
Sell
-46
Closed -$2K 704
2018
Q1
$2K Buy
+46
New +$2.16K ﹤0.01% 1596

Other funds holding GMED

Avantax Planning Partners's GMED Position: Q4 2018 in Review

Avantax Planning Partners sold out of Globus Medical (GMED) in Q4 2018, closing a stake of 46 shares — an estimated $3K sold.

Avantax Planning Partners first reported a position in GMED in Q1 2018 and held it in 2 quarters. The position peaked at $3K in Q3 2018. 303 funds tracked by Wall St. Rank hold GMED as of Q4 2018.

  • Avantax Planning Partners reported no remaining Globus Medical position as of Q4 2018 after selling out during the quarter.
  • Avantax Planning Partners sold 46 Globus Medical shares in Q4 2018, an estimated $3K.
  • Avantax Planning Partners first reported a position in Globus Medical in Q1 2018 and held it in 2 quarters.
  • Avantax Planning Partners's Globus Medical position peaked at $3K in Q3 2018.
  • 303 funds tracked by Wall St. Rank held Globus Medical as of Q4 2018.

Based on Avantax Planning Partners's 13F filing for Q4 2018, filed 14 Feb 2019.